Clinical Trial Update: A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing hydroxychloroquine versus placebo to prevent COVID-19 infection in patients receiving radiotherapy; study terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: COVID-19, Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-10-27